We are a reliable partner for Federal Ministries, State Ministries, the European Commission, governments outside of Europe, banks and associated companies, industry, research institutes and universities as well as other clients at home and abroad including the following:
-
Prima BioMed and Fraunhofer Institute in A$5.35m grant for CVac™ ovarian cancer trial …
Prima BioMed (ASX: PRR) has shared in a EUR 4.1 million (A$5.35 million) grant with the Fraunhofer Institute of Cell …
more